Spotlight
Topics
DI Executive
Subscribe
- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Can an Emerging AI Platform Enhance Real-Time Results for Mammography?
The combination of FDA-cleared AI software for mammography triage with a medical grade edge AI platform may allow the embedding of enhanced AI detection capability within existing mammography devices.
Could an embedded AI system within mammography devices provide enhanced images, bolster workflow efficiency, and reduce hardware upgrade costs?
MedCognetics said the combination of its CogNet AI-MT AI-powered mammography software with the medical-grade edge AI platform NVIDIA IGX Orin enables real-time processing of high-quality mammography images.
MedCognetics said the combination of CogNet AI-MT AI-powered mammography software with the medical-grade edge AI platform NVIDIA IGX Orin facilitates improved image clarity and detail as well as worklist prioritization for a significantly lower cost than hardware upgrades for mammography devices. (Images courtesy of MedCognetics.)
The combination of AI technologies reportedly facilitates improved image clarity and detail as well as worklist prioritization for a significantly lower cost than hardware upgrades for mammography devices, according to MedCognetics.
“Embedding our CogNet AI-MT software directly into mammography imaging equipment means we can enhance image quality and provide immediate cancer detection without the need for costly hardware upgrades,” said Debasish “Ron” Nag, the CEO of MedCognetics. “Using the NVIDIA IGX platform, we’re advancing medical imaging technology, making high-quality diagnostic tools more accessible to radiologists and imaging centers around the world.”
Recent Videos
Related Content
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024Article
The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
